Anderson J P, Brown S R, Johnson M A. "一种的合成方法" [P]. US Patent, US 10050420 B2, 2019-06-02.
Stevens L M, Park J H, Klinger H. "Method for the Synthesis of 5-(Piperidin-4-yl)-1,3,4-thiadiazol-2-amine" [P]. US Patent, US 11909182 B2, 2016-02-02.
发明人林芳,徐明华,陈志强. "A Process for Preparing High-Purity 5-(Piperidin-4-yl)-1,3,4-thiadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 111774734 B, 授权公告日 2019-06-08.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2021, 1817, 9791-9800.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2013, 1434, (4), 3292-3318.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 5-(Piperidin-4-yl)-1,3,4-thiadiazol-2-amine Using HRMS and NMR". Biomed. Chromatogr., 2010, 2216, (9), 1702-1708.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 590, (7), 9467-9486.